<unk>  is a monoclonal antibody that is FDA approved for the treatment of multiple sclerosis (MS) and Crohn's disease (CD). There is a Black Box Warning for this drug as shown here.  Common adverse reactions include headache, fatigue, arthralgia, urinary tract infection, lower respiratory tract infection, gastroenteritis, vaginitis, depression, pain in extremity, abdominal discomfort, diarrhea NOS, and rash.
Natalizumab
Palivizumab
Ravulizumab
Mogamulizumab
Motavizumab
Emicizumab
Ixekizumab
Caplacizumab